BACKGROUND: Evidence-based practices designed for large urban clinics are not necessarily portable into smaller isolated clinics. Implementing practice-based collaborative care for depression in smaller primary care clinics presents unique challenges because it is often not feasible to employ on-site psychiatrists. OBJECTIVE: The purpose of the Telemedicine Enhanced Antidepressant Management (TEAM) study was to evaluate a telemedicine-based collaborative care model adaptedfor small clinics without on-site psychiatrists. DESIGN: Matched sites were randomized to the intervention or usual care. PARTICIPANTS: Small VA Community-based outpatient clinics with no on-site psychiatrists, but access to telepsychiatrists. In 2003-2004, 395 primary care patients with PHQ9 depression severity scores > or = 12 were enrolled, and followed for 12 months. Patients with serious mental illness and current substance dependence were excluded. MEASURES: Medication adherence, treatment response, remission, health status, health-related quality of life, and treatment satisfaction. RESULTS: The sample comprised mostly elderly, white, males with substantial physical and behavioral health comorbidity. At baseline, subjects had moderate depression severity (Hopkins Symptom Checklist, SCL-20 = 1.8), 3.7 prior depression episodes, and 67% had received prior depression treatment. Multivariate analyses indicated that intervention patients were more likely to be adherent at both 6 (odds ratio [OR] = 2.1, p = .04) and 12 months (OR = 2.7, p = .01). Intervention patients were more likely to respond by 6 months (OR = 2.0, p = .02), and remit by 12 months (OR = 2.4, p = .02). Intervention patients reported larger gains in mental health status and health-related quality of life, and reported higher satisfaction. CONCLUSIONS: Collaborative care can be successfully adapted for primary care clinics without on-site psychiatrists using telemedicine technologies.
RCT Entities:
BACKGROUND: Evidence-based practices designed for large urban clinics are not necessarily portable into smaller isolated clinics. Implementing practice-based collaborative care for depression in smaller primary care clinics presents unique challenges because it is often not feasible to employ on-site psychiatrists. OBJECTIVE: The purpose of the Telemedicine Enhanced Antidepressant Management (TEAM) study was to evaluate a telemedicine-based collaborative care model adapted for small clinics without on-site psychiatrists. DESIGN: Matched sites were randomized to the intervention or usual care. PARTICIPANTS: Small VA Community-based outpatient clinics with no on-site psychiatrists, but access to telepsychiatrists. In 2003-2004, 395 primary care patients with PHQ9 depression severity scores > or = 12 were enrolled, and followed for 12 months. Patients with serious mental illness and current substance dependence were excluded. MEASURES: Medication adherence, treatment response, remission, health status, health-related quality of life, and treatment satisfaction. RESULTS: The sample comprised mostly elderly, white, males with substantial physical and behavioral health comorbidity. At baseline, subjects had moderate depression severity (Hopkins Symptom Checklist, SCL-20 = 1.8), 3.7 prior depression episodes, and 67% had received prior depression treatment. Multivariate analyses indicated that intervention patients were more likely to be adherent at both 6 (odds ratio [OR] = 2.1, p = .04) and 12 months (OR = 2.7, p = .01). Intervention patients were more likely to respond by 6 months (OR = 2.0, p = .02), and remit by 12 months (OR = 2.4, p = .02). Intervention patients reported larger gains in mental health status and health-related quality of life, and reported higher satisfaction. CONCLUSIONS: Collaborative care can be successfully adapted for primary care clinics without on-site psychiatrists using telemedicine technologies.
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston Journal: JAMA Date: 2002-12-11 Impact factor: 56.272
Authors: M Schoenbaum; J Unützer; C Sherbourne; N Duan; L V Rubenstein; J Miranda; L S Meredith; M F Carney; K Wells Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: Chuan-Fen Liu; Susan C Hedrick; Edmund F Chaney; Patrick Heagerty; Bradford Felker; Nicole Hasenberg; Stephan Fihn; Wayne Katon Journal: Psychiatr Serv Date: 2003-05 Impact factor: 3.084
Authors: Susan C Hedrick; Edmund F Chaney; Bradford Felker; Chuan-Fen Liu; Nicole Hasenberg; Patrick Heagerty; Jan Buchanan; Rocco Bagala; Diane Greenberg; Grady Paden; Stephan D Fihn; Wayne Katon Journal: J Gen Intern Med Date: 2003-01 Impact factor: 5.128
Authors: Gregory E Simon; Michael Von Korff; Evette J Ludman; Wayne J Katon; Carolyn Rutter; Jürgen Unützer; Elizabeth H B Lin; Terry Bush; Edward Walker Journal: Med Care Date: 2002-10 Impact factor: 2.983
Authors: Patrick R Finley; Heidi R Rens; Joan T Pont; Susan L Gess; Clifton Louie; Scott A Bull; Janelle Y Lee; Lisa A Bero Journal: Pharmacotherapy Date: 2003-09 Impact factor: 4.705
Authors: Terri L Barrera; Jeffrey A Cully; Amber B Amspoker; Nancy L Wilson; Cynthia Kraus-Schuman; Paula D Wagener; Jessica S Calleo; Ellen J Teng; Howard M Rhoades; Nicholas Masozera; Mark E Kunik; Melinda A Stanley Journal: J Anxiety Disord Date: 2015-05-07
Authors: John C Fortney; Jeffrey M Pyne; Sip B Mouden; Dinesh Mittal; Teresa J Hudson; Gary W Schroeder; David K Williams; Carol A Bynum; Rhonda Mattox; Kathryn M Rost Journal: Am J Psychiatry Date: 2013-04 Impact factor: 18.112
Authors: Kurt C Stange; Paul A Nutting; William L Miller; Carlos R Jaén; Benjamin F Crabtree; Susan A Flocke; James M Gill Journal: J Gen Intern Med Date: 2010-06 Impact factor: 5.128
Authors: Leonard E Egede; Christopher B Frueh; Lisa K Richardson; Ronald Acierno; Patrick D Mauldin; Rebecca G Knapp; Carl Lejuez Journal: Trials Date: 2009-04-20 Impact factor: 2.279